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S u m m a r y  
 
The aging process and systemic changes occurring in it 
have an impact on the brain. Commonly observed symptoms 
of an old age such as cognitive impairment and slowness of 
movement are the illustration of the changes in the brain. 
These changes are for brain structure, quantities of 
neurotransmitters and hormonal activity. We can partially 
modify the time and the dynamics of the development of 




S t r e s z c z e n i e  
 
Proces starzenia i ogólnoustrojowe zmiany w nim 
zachodzące nie pozostają bez wpływu na mózgowie. 
Powszechnie obserwowane objawy starości takie jak 
zaburzenia poznawcze, czy spowolnienie ruchowe są  
odzwierciedleniem zmian w mózgu. Zmiany te dotyczą 
struktury mózgu, ilości neurotransmitterów czy aktywności 
hormonalnej. Częściowo możemy modyfikować czas i 
dynamikę rozwoju zmian inwolucyjnych, poprzez właściwe 
działania profilaktyczne. 
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In the last 50 years of the 20th century the average 
life expectancy extended by nearly 20 years. In the 
developed countries population of people under 65 is 
about 14% of the society. For the developing countries 
these statistics are determined at the level of 5 % [1].In 
Poland this coefficient is 13.6% which puts us just 
behind the developed countries (according to the report 
from the period of 2010-2011).An increasing 
proportion of older people in the population presents 
new challenges for modern medicine. The age under 65 
is characterized by a significant increase in memory 
disorders as well as cognitive dysfunction. The risk of 
depression in this group of people is between 10-20% 
and very often occurs with senile dementia [2]. 
 
CEREBRAL TISSUE VOLUME 
 
Human brain represents about 2% of the entire 
weight of the body. Its volume reaches a maximum at 
the age of about 20-40 years. The body of an adult is 
made up of 60-65% of water. In older people this ratio 
drops to about 50-55%.Lower hydration of the whole 
body is also reflected in brain tissues. Cytoplasm 
volume in every neuron decreases which leads to an 
individual neurons’ reduction in volume. There is no 
change in the volume of the extracellular space. 
Decrease in brain volume is strictly connected with the 
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intracellular changes in nervous tissues. Mass of the 
brain decreases between the 3rd and the 8th decade of 
life by about 10%[3].Not all of the brain structures lose 
the same volume of water in connection with the loss 
of water. Cortical centers consisting of small neurons 
lose only about 5-8% of its surface. Losses in the fields 
of somatosensory and motor cortex are composed of 
large neurons and reach even 15%.Starting from the 
age of 25 a hippocampal mass decreases by about 2-
3% in 10 years. The rate of decline increases after 75 
and is up to1% per year. [4].Mass of the white matter 
of the brain decreases quite evenly. Loss of the grey 
matter is characterized by differentiation that depends 
on the region of the brain. The defects in the frontal 
and parental cortex are distinct. Smaller losses are 
recorded in  temporal and occipital cortex[5]. 
  
PLASTICITY IN THE BRAIN AND CHANGES  
IN NEURONS 
 
Reduction of intracellular water translates directly 
into increased protein content inside the neuron. This 
way the neurons can accumulate pathological proteins-
amyloids interfering with their function. As the body 
grows older, the volume of glial cells in the brain 
increases. The rate of synthesis of myelin decreases 
although the astrocytes are not dimnished. The length 
of myelinated axons decreases by approximately 27-
34%[3]. Impoverishment of a dendritic tree occurs in 
the aging neuron as well as disappearance of the spikes 
and reduction of the number of synaptic connections. 
The nerve cells' ability to multiply decreases which 
leads to a reduction in their total 
number[6].Cerebellum is very sensitive to change in 
reducing number of neurons(the largest number of 
dying Purkinje cells).Significant morphological 
changes occur in the brain motor cortex. Dysfunction 
of the brain structures and motor cortex is often the 
cause of imbalances and coordination in the elderly. 
An adult up to 80 years looses an average of 3-5% of 
the nerve cells in comparison to the value in adulthood. 
The greatest loss of neurons occurs in the cerebral 
cortex (10-17%) and striatum(8%).The processes of 
neurogenesis and synaptogenesis slow down with age. 
The number of synapses and dendritic branching 
decreases. The ability to create persistent interneuronal 
connections is reduced. Creating new connections 
between neurons may be impeded by the specific types 
of proteins and insoluble pigments that accumulate in 
the intercellular space. Lipofuscin, neuromelanin and 
senile plaques belong to them[6,8].Brain has a natural 
ability to adapt through the reorganization of its 
structures, synaptogenesis and neurogenesis. The 
younger person’s the brain plasticity is 
greater[7].Injuries or damages to the brain at  early age 
give big changes to almost full or total restoration 
 function of the damaged parts o f the brain in 
undamaged areas of the brain. Plasticity allows us to 
adapt to changing external and internal environment. 
With the ability to structural and functional 
reorganization, brain is capable of self-repair, 
adaptation, learning and remembering. 
                 
VASCULAR CHANGES  
 
 Cerebral vessels become less flexible, thinner and 
more susceptible to damage with age [9].Disorders of 
the proportion of collagen compared to elastin lead to 
the unfavorable changes in blood vessels. The level of 
elastin in vessels decreases  and collagen grows. 
Vascular endothelium becomes less excitable on the 
action of acetylcholine and bradykinin. The vessel 
calcification and stiffness as well as smooth muscle 
hypertrophy occur [10]. 
With age synthesis of nitric oxide decreases (NO) 
NO gives relaxant effects as well as works extensively 
on vessels and takes part in the regulation of blood 
flow [11].Development of atherosclerosis is a frequent 
problem in the elderly. Cerebral atherosclerosis impairs 
perfusion and autoregulation of blood flow. This leads 
to deterioration of brain metabolism, its under-nutrition 
and oxygenation. These changes increase the risk of 
cerebral stroke [4,12]. 
  
NEUROTRANSMISSION IN THE ELDERLY 
 
The greatest decline of neurotransmitters is 
noticeable in a dopaminergic, cholinergic and 
serotonergic system. The decrease also applies to other 
neurotransmitters e.g.dehydroepiandrosterone, GABA 
acids. Reducing the amount of neurotransmitter, 
worsening its receptor, binding and loss of adequate 
receptors for neurotransmitter are the cause of the 
impaired neurotransmission [6]. 
  
SEROTONERGIC AND GLUTANERGIC SYSTEM 
 
Disorders of the serotoergic transmission may be the 
cause of depressive disorders and depression 
[13].Glutamic acid is one of the most important 
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neurotransmitters that stimulate our brain to act. 
Activating actions on neurons  give positive effects on 
the entire brain. Over the years, there has been an 
increase of receptors AMPA compared to NMDA in 





There is a clear correlation between the level of the 
brain cortex and the incidence and severity of dementia 
changes. The number of cholinergic cells in the 
Meynert nucleus drops by about 25-70%.This leads to 
a significant decrease in neurotransmitter because in 
Meynert nucleus there is about 90% of synthesized 
acetylcholine. The activity of choline acetyltransferase-





Impairment of dopaminergic transmission largely 
depends on reducing the number of dopamine receptors 
D1 D2 in the caudate in putamen (?).The ability to bind 
dopamine decreases. Significant reduction of the 
number of dopamine receptors occurs in the nigra 
substantia. Dopamine reuptake also decreases 
[13].Dopamine level decreases by about 6% for each 
decade after 40 years of age. The loss of substantia 
nigra cells after 65 reaches even 10% per decade. 
Dopamine deficiency can lead to disorders of motor 
function such as problems with coordination of 
movements and slowness  of walking and movement. 
[7]. 
  
DEHEDROEPIANDROSTERONE  (DHEA) 
 
Dehydroepiandrosterone boosts the process of new 
neuron formation as well as enhances memoryband 
calms. A total concentration of DHEA in the body is 
observed between 20-30 years. Cortisol working 
destructive to neurons is released in stressful situations. 
Dehydroepiandrosterone acts neuroprotectively and 
protects neurons from the toxic effects of cortisol 
[15].DHEA decrease is more severe in men. It is 
strictly connected with the disappearance  of reticular 
layerbof the adrenal cortex which produces DHEA 
[12].DHEA has also an antioxidant, anti-depressant, 
anti-sclerotic and improving memory influence [10]. 
  
GAMMA-AMINO-BUTYRIC ACID  
AND MELATONIN  
 
GABA plays an important role as a neurotransmitter 
in the inhibitory synapses. Stimulation of the receptors 
leads to opening the chloride  channel and 
hyperpolarization of postsynaptic membrane. GABA is 
necessary for the psychomotor calm and for reducing 
muscle tension. Decreased GABA may cause epileptic 
seizures, restless leg syndrome and difficulty in falling 
asleep [8].Melatonin is working agonist hormone in 
relation to the GABA produced in the pineal gland. Its 
secretion declines with age which is associated with 
sleep disturbance and deterioration of its quality 
[13].The reuptake of the neurotransmitter in the body 
also decreases [14]. 
  
PATHOLOGICAL CONDITIONS ASSOCIATED 
WITH NEUROTRANSMISSION DISORDERS 
 
We can see how important GABA is for our body 
watching people with the Huntington disease. Drastic 
decrease in the neurotransmitter is responsible for 
dyskinesias and for the characteristic movements 
occurring in this disease[8]. Alzheimer’s disease is 
associated with an excessive acetylcholine decrease to 
a lesser extent with norepinephrine, dopamine and 
serotonin. In Parkinson's disease such clinical signs as 
an increased muscle tone stooped posture of a body or 
motor dysfunction are caused by dopamine deficiency. 
We have to keep in mind that the physiological 
neurotransmitters' decline is natural in the elderly. The 
diseases listed above take place when the level of 





Aging is an inevitable process. We cannot stop all the 
changes that take place in our body but by appropriate 
preventive actions we can significantly slow them 
down. Focusing on maintaining a good brain condition 
we should especially take care of a good diet and 
regular mental activity. Through mental activity we 
can understand all the activities forcing our brain to 
work harder. This can be presented by crosswords, 
games requiring logical thinking e.g. chess or work, 
familly and social life [12]. If we want our diet to be 
correct, we cannot miss such ingredients as A B 
vitamin (especially B3 B6 B9 B12 C E K) as well as 
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minerals and microelements such as phosphorus, 
potassium, magnesium, zinc and boron. Such a diet 
supports activity of the brain, has a neuroprotective 




Despite the changes that occur with age in our brain, 
the old age should not only be considered in terms of 
loss. 
At the age of about 75 years of age our brain has 
significant possibilities for compensation arising from 
the deficiencies of aging processes. Such an action is 
even more complex dendritic tree in the elderly. These 
abilities are clearly smaller after finishing 75 years of 
age but still exist[18].An appropriate preventive can 
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